October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

C68 Malignant neoplasm of other and unspecified urinary organs

All 4 codes in the C68 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

4

Can lead a claim

3

Cannot lead a claim

1

What CMS assigns to C68

3 of the 4 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases; 1 is assigned no clinical group. 3 of the 4 count toward the Malignant Neoplasm of Urinary Tract comorbidity subgroup; 1 is assigned none. 3 of the 4 can lead a claim.

  • Malignant Neoplasm of Urinary Tract

Every code in C68

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
C68.0Malignant neoplasm of urethraCan lead a claimKMalignant Neoplasm of Urinary Tract
C68.1Malignant neoplasm of paraurethral glandsCan lead a claimKMalignant Neoplasm of Urinary Tract
C68.8Malignant neoplasm of overlapping sites of urinary organsCan lead a claimKMalignant Neoplasm of Urinary Tract
C68.9Malignant neoplasm of urinary organ, unspecifiedCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue